Pharmacometabonomics in humans: a new tool for personalized medicine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacometabonomics in humans: a new tool for personalized medicine
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 16, Issue 7, Pages 737-754
Publisher
Future Medicine Ltd
Online
2015-05-01
DOI
10.2217/pgs.15.20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A New Paradigm for Known Metabolite Identification in Metabonomics/Metabolomics: Metabolite Identification Efficiency
- (2015) Jeremy R. Everett Computational and Structural Biotechnology Journal
- Precision High-Throughput Proton NMR Spectroscopy of Human Urine, Serum, and Plasma for Large-Scale Metabolic Phenotyping
- (2014) Anthony C. Dona et al. ANALYTICAL CHEMISTRY
- Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions
- (2014) Munir Pirmohamed Annual Review of Genomics and Human Genetics
- The emerging era of pharmacogenomics: current successes, future potential, and challenges
- (2014) J.W. Lee et al. CLINICAL GENETICS
- The Pharmacogenetics of Type 2 Diabetes: A Systematic Review
- (2014) Nisa M. Maruthur et al. DIABETES CARE
- Metabolite identification: are you sure? And how do your peers gauge your confidence?
- (2014) Darren J. Creek et al. Metabolomics
- An atlas of genetic influences on human blood metabolites
- (2014) So-Youn Shin et al. NATURE GENETICS
- 'Personalized medicine': what’s in a name?
- (2014) Anna Pokorska-Bocci et al. Personalized Medicine
- Genome-Wide Association Study of Metabolic Traits Reveals Novel Gene-Metabolite-Disease Links
- (2014) Rico Rueedi et al. PLoS Genetics
- Pharmacogenomics: Current State-of-the-Art
- (2014) Daniel Carr et al. Genes
- Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization
- (2013) Philip G. Joseph et al. CLINICAL CARDIOLOGY
- Pharmacogenomic Testing and Personalized Treatment of Depression
- (2013) R. H. Perlis CLINICAL CHEMISTRY
- Integration of Pharmacometabolomic and Pharmacogenomic Approaches Reveals Novel Insights Into Antiplatelet Therapy
- (2013) J P Lewis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics
- (2013) L M Yerges-Armstrong et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance
- (2013) K-H Shin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
- (2013) Abdul-Hamid M. Emwas et al. Metabolomics
- Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
- (2013) William R. Wikoff et al. PLoS One
- Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
- (2013) Hongjie Zhu et al. PLoS One
- Characterization of biopharmaceuticals by NMR spectroscopy
- (2013) David S. Wishart TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
- (2013) R Kaddurah-Daouk et al. Translational Psychiatry
- Pharmacometabonomics and personalized medicine
- (2013) Jeremy R Everett et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
- (2012) Vassilios Fanos et al. CURRENT PHARMACEUTICAL DESIGN
- Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy
- (2012) Jeremy K Nicholson et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmaceutical research and metabolomics in the newborn
- (2012) Roberto Antonucci et al. Journal of Maternal-Fetal & Neonatal Medicine
- Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics
- (2012) Warwick B. Dunn et al. Metabolomics
- Novel biomarkers for pre-diabetes identified by metabolomics
- (2012) Rui Wang-Sattler et al. Molecular Systems Biology
- Genome-wide association study identifies multiple loci influencing human serum metabolite levels
- (2012) Johannes Kettunen et al. NATURE GENETICS
- HMDB 3.0—The Human Metabolome Database in 2013
- (2012) David S. Wishart et al. NUCLEIC ACIDS RESEARCH
- Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis
- (2012) Ana Miguel et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation
- (2012) Ryan Abo et al. Pharmacogenetics and Genomics
- Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
- (2012) Miles Trupp et al. PLoS One
- Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
- (2011) A. Backshall et al. CLINICAL CANCER RESEARCH
- A challenging drug development process in the era of personalized medicine
- (2011) Jan Trøst Jørgensen DRUG DISCOVERY TODAY
- 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
- (2011) Ruth Condray et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prediction of Variability in CYP3A4 Induction Using a Combined1H NMR Metabonomics and Targeted UPLC–MS Approach
- (2011) Nilufer Rahmioglu et al. JOURNAL OF PROTEOME RESEARCH
- Human metabolic individuality in biomedical and pharmaceutical research
- (2011) Karsten Suhre et al. NATURE
- A genome-wide association study of metabolic traits in human urine
- (2011) Karsten Suhre et al. NATURE GENETICS
- Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
- (2011) Rima Kaddurah-Daouk et al. PLoS One
- Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
- (2011) R Kaddurah-Daouk et al. Translational Psychiatry
- Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics
- (2010) Y Ji et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Use of Pharmaco-Metabonomics for Early Prediction of Acetaminophen-Induced Hepatotoxicity in Humans
- (2010) J H Winnike et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An Integrative Approach for Identifying a Metabolic Phenotype Predictive of Individualized Pharmacokinetics of Tacrolimus
- (2010) P B Phapale et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
- (2010) Rima Kaddurah-Daouk et al. Metabolomics
- Pharmacometabonomics as an effector for personalized medicine
- (2010) Jeremy K Nicholson et al. PHARMACOGENOMICS
- Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
- (2009) H. C. Keun et al. CLINICAL CANCER RESEARCH
- Drugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring
- (2009) I. D. Wilson PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
- (2009) T. A. Clayton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spectroscopic and Statistical Techniques for Information Recovery in Metabonomics and Metabolomics
- (2008) John C. Lindon et al. Annual Review of Analytical Chemistry
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started